69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] VICCPHI1449 10/27/2014 [Summary] A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial Cancer [Trial Type] 
Treatment Urologic
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type